DOI: 10.1055/s-00000059

Pneumologie

Referenz

Berger W, Gupta N, McAlary M. et al.
Evaluation of long-term safety of the anti-IgE antibody, omalizumab, in children with allergic asthma. 
Ann Allergy Asthma Immunol 2003; 91: 182-188  

Bibliographische Angaben herunterladen

Suchen in: